GOSS Gossamer Bio, Inc.
10.18USD-5.57%Mkt Cap: 62.26M $P/E: —1d ago
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. …
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap62.26M USD
Enterprise Value48.91M USD
Revenue (TTM)53.29M USD
Gross Profit53.29M USD
Net Income (TTM)-170.37M USD
Revenue/Share16.81 USD
Last Price10.18 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees161
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.69
PEG—
EV/EBITDA-0.31
EV/Revenue0.92
P/S1.24
P/B-56.15
EPS (TTM)-52.80
EPS (Forward)-15.61
52W Range
9.1040% of range309.60
52W High309.60 USD
52W Low9.104 USD
Profitability
Gross Margin100.00%
Oper. Margin-282.25%
EBITDA Margin-297.63%
Profit Margin-351.49%
ROE138.78%
ROA-98.91%
Growth
Revenue Growth-19.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-171.27M USD
CapEx (TTM)79.00K USD
FCF Margin-55.86%
FCF Yield-47.80%
Net Debt-16.96M USD
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity-1.65
Current Ratio0.53
Quick Ratio0.46
Book Value/Sh-0.19 USD
Cash/Share9.33 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:80
Split DateSep 11, 2026
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)82.48 USD
Upside (mean)+710.2%
Target Range22.40 USD – 120.00 USD
22.40+710.2% to mean120.00
# Analysts5
Ownership
Shares Out.6.12M
Float3.88M
Insiders1.43%
Institutions84.88%
Short Interest
Short Ratio3.3d
Short % Float15.73%
Short % Out.15.51%
Shares Short948.62K
Short (prev mo.)1.08M
Technical
SMA 5012.89 (-21.0%)
SMA 20063.02 (-83.8%)
Beta2.21
S&P 52W Chg16.45%
Avg Vol (30d)326.55K
Avg Vol (10d)357.21K
Technical Indicators
RSI (14)37.2
MACD-0.6164
MACD Signal-0.5979
MACD Hist.-0.0186
BB Upper13.15 USD
BB Middle11.26 USD
BB Lower9.368 USD
BB Width33.56%
ATR (14)1.247 USD
Vol Ratio (20d)0.90x